Allergy and Cold Medications in PAH

Springtime is beautiful. The cold of winter leaves and the flowers begin to bloom. And pollen counts soar! Many people are sensitive to the rising pollen counts and experience seasonal allergies. Common symptoms include itchy eyes, runny nose, sneezing, cough or scratchy throat. Though not life-threatening these symptoms can make us miserable. Pulmonary Hypertension patients … [Read more...]

Massachusetts – First State to Create PAH Task Force

  The first PAH State Task Force has been created in Massachusetts. The purpose of the force is to monitor and report annually on advances in research, lung transplantation, public awareness, health care delivery and improvements in early and accurate diagnosis all of which will affect how health care professionals provide care for patients with Pulmonary Arterial … [Read more...]

3 Tips to Help PAH Patients Cope with Allergies

You know what they say: April showers bring May flowers…..and allergies. The nasal congestion, running nose, itchy eyes and sore throat can be a pain for anyone suffering from allergies. These symptoms are especially bothersome for Pulmonary Hypertension patients. Read below for 3 tips to help PAH patients get through allergy season. 1.     Nasal Lubricant Many PAH … [Read more...]

New Option for Sub-Cutaneous Drug Delivery Coming Soon

The SteadyMed PatchPump SteadyMed is a new company to the PAH disease state.  They have a novel small subcutaneous pump system (PatchPump) that is being studied for the delivery of Treprostinil (the generic version of Remodulin).  The version of Treprostinil that is included in the pump is called Trevyent and is free of preservatives.   The company just recently reported a … [Read more...]

Update on the Implanted Remodulin Pump

This week we learned that the much-awaited arrival of the Implanted Pump System for Remodulin would be further delayed.  The FDA did not grant Medtronic and United Therapeutics approval.  Details are scant but the announcement indicated that the device might be approved in the beginning of 2018. PAH Patients and doctors alike were let down by the delay.  The delay does not … [Read more...]